Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II

FDA inspection history in Pithampur, India, 2017 to 2025

3
Form 483s

Every document, by year

  • Form 483

2017: one Form 483; 2018: one Form 483; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–18Two Form 483s, at Pithampur, India.
  2. 2018The longest 483 on file: 5 observations over 6 pages at Pithampur, India.
  3. 2025One Form 483, at Pithampur, India.

Cited most

Across all Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II observations on file

The complete Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2025-07-17483 Form 483$99
2018-10-18483 Form 483$99
2017-06-16483 Form 483$99

FEI number 3009107538 · most recent document Jul 17, 2025

About Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II

How many FDA Form 483s has Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II received?

FDA Intel has 3 Form 483s on file for Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II; the most recent is dated Jul 17, 2025.

When was Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II last inspected by FDA?

The most recent FDA inspection document on file for Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II is a Form 483 dated Jul 17, 2025, for the site in Pithampur, India.

What did FDA cite at Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II?

The regulations cited most in the observations on file for Lupin Limited Unit 3, Plot No. M-1, SEZ, Phase II are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 3 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.192 (Production record review), 2 times.